Braidwell »

Lantheus Holdings Inc Common Stock Usd 0.01 shares owned by Braidwell

Quarter-by-quarter ownership of Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Lantheus Holdings Inc Common Stock Usd 0.01

Tip: Access up to 7 years of quarterly data

All positions including Lantheus Holdings Inc Common Stock Usd 0.01 held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantheus Holdings Inc Common Stock Usd 0.01 by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $31M 495k 62.00
2023-09-30 $20M 288k 69.48

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Lantheus Holdings Inc Common Stock Usd 0.01

Vanguard Group
Henderson Group
Alliancebernstein
T. Rowe Price Associates
Westfield Capital Management Company
Reinhart Mahoney Capital Management
Citadel Advisors
Dimensional Fund Advisors
Charles Schwab Investment Management
Balyasny Asset Management
Wells Fargo & Company
Bank of New York Mellon
Bank of America Corporation
Robeco Investment Management
Private Capital Management

View all funds holding Lantheus Holdings Inc Common Stock Usd 0.01